Session

IBD (Posters)

SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE
SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE

IBD (Posters)  et al.

REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD
REGULATORS OF THE GUANYLATE CYCLASE PATHWAY ARE POTENTIAL NOVEL MARKERS OF MUCOSAL HEALING IN IBD

IBD (Posters)  et al.

THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN´S DISEASE (CD)
THE POTENTIAL ROLE OF PROCALCITONIN AS A NOVEL SERUM INFLAMMATORY BIOMARKER IN ULCERATIVE COLITIS (UC) AND CROHN´S DISEASE (CD)

IBD (Posters)  et al.

PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE
PROACTIVE INFLIXIMAB DRUG MONITORING INDUCES FECAL BIOMARKER REMISSION IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB
CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB

IBD (Posters)  et al.

TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE
TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY
ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY

IBD (Posters)  et al.

INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN´S DISEASE
INTESTINAL ULTRASOUND IN MONITORING POSTOPERATIVE CROHN´S DISEASE

IBD (Posters)  et al.

VALIDATION OF GROWTH STUDY IN A PROSPECTIVE INCEPTION COHORT OF PEDIATRIC CD PATIENTS
VALIDATION OF GROWTH STUDY IN A PROSPECTIVE INCEPTION COHORT OF PEDIATRIC CD PATIENTS

IBD (Posters)  et al.

AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
AGE RELATED PREVALENCE OF SEXUAL AND ERECTYLE DYSFUNCTION AND LOW QUALITY OF LIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS
AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

IBD (Posters)  et al.

THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE
THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

HISTOLOGICAL ACTIVITY SCORE IN CROHN'S DISEASE: A REAL LIFE 1-YEAR PROSPECTIVE STUDY
HISTOLOGICAL ACTIVITY SCORE IN CROHN'S DISEASE: A REAL LIFE 1-YEAR PROSPECTIVE STUDY

IBD (Posters)  et al.

PERIANAL CROHN'S DISEASE IN CHILDREN IS ASSOCIATED WITH MORE HOSPITALIZATIONS AND SURGERIES DESPITE HIGHER UTILIZATION OF IMMUNOMODULATORS AND BIOLOGICS: A REPORT FROM THE EPIIIRN COHORT
PERIANAL CROHN'S DISEASE IN CHILDREN IS ASSOCIATED WITH MORE HOSPITALIZATIONS AND SURGERIES DESPITE HIGHER UTILIZATION OF IMMUNOMODULATORS AND BIOLOGICS: A REPORT FROM THE EPIIIRN COHORT

IBD (Posters)  et al.

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN BIOLOGIC-NAïVE PATIENTS: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)
EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN BIOLOGIC-NAïVE PATIENTS: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)

IBD (Posters)  et al.

EXPLORING HYPOPHOSPHATAEMIA: HOW FREQUENTLY DOES IT OCCUR IN INFLAMMATORY BOWEL DISEASE AND WHAT ARE THE IMPLICATIONS FOR INTRAVENOUS IRON THERAPY?
EXPLORING HYPOPHOSPHATAEMIA: HOW FREQUENTLY DOES IT OCCUR IN INFLAMMATORY BOWEL DISEASE AND WHAT ARE THE IMPLICATIONS FOR INTRAVENOUS IRON THERAPY?

IBD (Posters)  et al.

SEROLOGICAL MARKERS OF EXTRACELLULAR MATRIX REMODELING REFLECTS ENDOSCOPIC DISEASE ACTIVITY AND SEVERITY IN CROHN'S DISEASE AND ULCERATIVE COLITIS
SEROLOGICAL MARKERS OF EXTRACELLULAR MATRIX REMODELING REFLECTS ENDOSCOPIC DISEASE ACTIVITY AND SEVERITY IN CROHN'S DISEASE AND ULCERATIVE COLITIS

IBD (Posters)  et al.

CLINICAL RESPONSE TO AZATHIOPRINE IS ASSOCIATED WITH SPECIFIC METABOLIC SHIFT TOWARDS THIOGUANINE DI- AND TRI-PHOSPHATES
CLINICAL RESPONSE TO AZATHIOPRINE IS ASSOCIATED WITH SPECIFIC METABOLIC SHIFT TOWARDS THIOGUANINE DI- AND TRI-PHOSPHATES

IBD (Posters)  et al.

SYSTEMIC AND ORALLY ADMINISTRATION OF AC2-26 LOADED NANOPARTICLES INDUCES ANASTOMOTIC HEALING IN A MODEL OF LOCALLY INDUCED TNBS COLITIS
SYSTEMIC AND ORALLY ADMINISTRATION OF AC2-26 LOADED NANOPARTICLES INDUCES ANASTOMOTIC HEALING IN A MODEL OF LOCALLY INDUCED TNBS COLITIS

IBD (Posters)  et al.

EFFECTIVENESS OF USTEKINUMAB ON CROHN´S DISEASE ASSOCIATED SPONDYLOARTROPATHY
EFFECTIVENESS OF USTEKINUMAB ON CROHN´S DISEASE ASSOCIATED SPONDYLOARTROPATHY

IBD (Posters)  et al.

Item 501 - 520 / 558
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
26
27 28